These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 11778663)

  • 1. Lead poisoning treatment--a continuing need (commentary).
    Shannon M
    J Toxicol Clin Toxicol; 2001; 39(7):661-3. PubMed ID: 11778663
    [No Abstract]   [Full Text] [Related]  

  • 2. Lead poisoning prevention, not chelation (commentary).
    Henretig F
    J Toxicol Clin Toxicol; 2001; 39(7):659-60. PubMed ID: 11778662
    [No Abstract]   [Full Text] [Related]  

  • 3. Primary prevention of childhood lead poisoning--the only solution.
    Rosen JF; Mushak P
    N Engl J Med; 2001 May; 344(19):1470-1. PubMed ID: 11346814
    [No Abstract]   [Full Text] [Related]  

  • 4. The impact of succimer chelation on blood cadmium in children with background exposures: a randomized trial.
    Cao Y; Chen A; Bottai M; Caldwell KL; Rogan WJ
    J Pediatr; 2013 Aug; 163(2):598-600. PubMed ID: 23601497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of chelation therapy on the neuropsychological and behavioral development of lead-exposed children after school entry.
    Dietrich KN; Ware JH; Salganik M; Radcliffe J; Rogan WJ; Rhoads GG; Fay ME; Davoli CT; Denckla MB; Bornschein RL; Schwarz D; Dockery DW; Adubato S; Jones RL;
    Pediatrics; 2004 Jul; 114(1):19-26. PubMed ID: 15231903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of chelation therapy with succimer on neuropsychological development in children exposed to lead.
    Rogan WJ; Dietrich KN; Ware JH; Dockery DW; Salganik M; Radcliffe J; Jones RL; Ragan NB; Chisolm JJ; Rhoads GG;
    N Engl J Med; 2001 May; 344(19):1421-6. PubMed ID: 11346806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do children with falling blood lead levels have improved cognition?
    Liu X; Dietrich KN; Radcliffe J; Ragan NB; Rhoads GG; Rogan WJ
    Pediatrics; 2002 Oct; 110(4):787-91. PubMed ID: 12359796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chelation therapy in children exposed to lead.
    Shannon M; Woolf A; Binns H
    N Engl J Med; 2001 Oct; 345(16):1212-3. PubMed ID: 11642245
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of chelation in the treatment of lead poisoning: discussion of the Treatment of Lead-Exposed Children Trial (TLC).
    McKay CA
    J Med Toxicol; 2013 Dec; 9(4):339-43. PubMed ID: 24178899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of children with elevated blood lead levels.
    Kim D; Buchanan S; Noonan G; McGeehin M
    Am J Prev Med; 2002 Jan; 22(1):71. PubMed ID: 11777685
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of lead-exposed children.
    Rhoads GG; Rogan WJ
    Pediatrics; 1996 Jul; 98(1):162-3. PubMed ID: 8668397
    [No Abstract]   [Full Text] [Related]  

  • 12. Succimer chelation improves learning, attention, and arousal regulation in lead-exposed rats but produces lasting cognitive impairment in the absence of lead exposure.
    Stangle DE; Smith DR; Beaudin SA; Strawderman MS; Levitsky DA; Strupp BJ
    Environ Health Perspect; 2007 Feb; 115(2):201-9. PubMed ID: 17384765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unanswered questions in metal chelation.
    Kosnett MJ
    J Toxicol Clin Toxicol; 1992; 30(4):529-47. PubMed ID: 1331492
    [No Abstract]   [Full Text] [Related]  

  • 14. Modeling the effect of succimer (DMSA; dimercaptosuccinic acid) chelation therapy in patients poisoned by lead.
    van Eijkeren JC; Olie JD; Bradberry SM; Vale JA; de Vries I; Clewell HJ; Meulenbelt J; Hunault CC
    Clin Toxicol (Phila); 2017 Feb; 55(2):133-141. PubMed ID: 27919185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Treatment of Lead-exposed Children (TLC) trial: design and recruitment for a study of the effect of oral chelation on growth and development in toddlers.
    Paediatr Perinat Epidemiol; 1998 Jul; 12(3):313-33. PubMed ID: 9690266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The scientific basis for chelation: animal studies and lead chelation.
    Smith D; Strupp BJ
    J Med Toxicol; 2013 Dec; 9(4):326-38. PubMed ID: 24113857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of succimer on growth of preschool children with moderate blood lead levels.
    Peterson KE; Salganik M; Campbell C; Rhoads GG; Rubin J; Berger O; Ware JH; Rogan W
    Environ Health Perspect; 2004 Feb; 112(2):233-7. PubMed ID: 14754579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of succimer chelation for reducing brain Pb levels in a rodent model.
    Smith D; Bayer L; Strupp BJ
    Environ Res; 1998 Aug; 78(2):168-76. PubMed ID: 9719621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic efficiency of succimer used with calcium and ascorbic acid in the treatment of mild lead-poisoning.
    Jin Y; Yu F; Liao Y; Liu S; Liu M; Xu J; Yang J
    Environ Toxicol Pharmacol; 2011 Jan; 31(1):137-42. PubMed ID: 21787678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of succimer chelation for reducing brain lead in a primate model of human lead exposure.
    Cremin JD; Luck ML; Laughlin NK; Smith DR
    Toxicol Appl Pharmacol; 1999 Dec; 161(3):283-93. PubMed ID: 10620486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.